nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—MAPK14—coronary artery disease	0.171	0.459	CbGaD
Dasatinib—JAK2—coronary artery disease	0.13	0.348	CbGaD
Dasatinib—KIT—coronary artery disease	0.0722	0.193	CbGaD
Dasatinib—ABCG2—Pitavastatin—coronary artery disease	0.0153	0.0601	CbGbCtD
Dasatinib—ABCG2—Telmisartan—coronary artery disease	0.0153	0.0601	CbGbCtD
Dasatinib—ABCG2—Rosuvastatin—coronary artery disease	0.0113	0.0443	CbGbCtD
Dasatinib—ABCG2—Ezetimibe—coronary artery disease	0.0113	0.0443	CbGbCtD
Dasatinib—ABCG2—Pravastatin—coronary artery disease	0.0102	0.0403	CbGbCtD
Dasatinib—ABCB1—Ticagrelor—coronary artery disease	0.0102	0.0401	CbGbCtD
Dasatinib—CYP3A5—Clopidogrel—coronary artery disease	0.00968	0.0381	CbGbCtD
Dasatinib—CYP3A5—Eplerenone—coronary artery disease	0.009	0.0354	CbGbCtD
Dasatinib—CYP1A2—Gemfibrozil—coronary artery disease	0.00831	0.0327	CbGbCtD
Dasatinib—CYP1A2—Clopidogrel—coronary artery disease	0.00721	0.0283	CbGbCtD
Dasatinib—ABCB1—Perindopril—coronary artery disease	0.0063	0.0248	CbGbCtD
Dasatinib—ABCB1—Clopidogrel—coronary artery disease	0.0063	0.0248	CbGbCtD
Dasatinib—CYP3A5—Rosuvastatin—coronary artery disease	0.00624	0.0245	CbGbCtD
Dasatinib—CYP3A4—Ticagrelor—coronary artery disease	0.00611	0.024	CbGbCtD
Dasatinib—CYP3A5—Simvastatin—coronary artery disease	0.0058	0.0228	CbGbCtD
Dasatinib—CYP3A5—Pravastatin—coronary artery disease	0.00568	0.0223	CbGbCtD
Dasatinib—CYP3A5—Lovastatin—coronary artery disease	0.00568	0.0223	CbGbCtD
Dasatinib—ABCB1—Pitavastatin—coronary artery disease	0.00551	0.0217	CbGbCtD
Dasatinib—ABCB1—Telmisartan—coronary artery disease	0.00551	0.0217	CbGbCtD
Dasatinib—CYP3A4—Fenofibrate—coronary artery disease	0.00545	0.0214	CbGbCtD
Dasatinib—ABCB1—Lisinopril—coronary artery disease	0.00522	0.0205	CbGbCtD
Dasatinib—ABCB1—Enalapril—coronary artery disease	0.00522	0.0205	CbGbCtD
Dasatinib—CYP3A5—Atorvastatin—coronary artery disease	0.00517	0.0203	CbGbCtD
Dasatinib—CYP3A5—Losartan—coronary artery disease	0.00473	0.0186	CbGbCtD
Dasatinib—ABCB1—Timolol—coronary artery disease	0.00444	0.0175	CbGbCtD
Dasatinib—CYP3A4—Gemfibrozil—coronary artery disease	0.00436	0.0171	CbGbCtD
Dasatinib—ABCB1—Ezetimibe—coronary artery disease	0.00406	0.016	CbGbCtD
Dasatinib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00396	0.0156	CbGbCtD
Dasatinib—ABCB1—Captopril—coronary artery disease	0.00391	0.0154	CbGbCtD
Dasatinib—CYP3A4—Clopidogrel—coronary artery disease	0.00378	0.0148	CbGbCtD
Dasatinib—ABCB1—Simvastatin—coronary artery disease	0.00378	0.0148	CbGbCtD
Dasatinib—ABCB1—Lovastatin—coronary artery disease	0.00369	0.0145	CbGbCtD
Dasatinib—ABCB1—Pravastatin—coronary artery disease	0.00369	0.0145	CbGbCtD
Dasatinib—CYP1A2—Losartan—coronary artery disease	0.00352	0.0138	CbGbCtD
Dasatinib—CYP3A4—Eplerenone—coronary artery disease	0.00351	0.0138	CbGbCtD
Dasatinib—ABCB1—Atorvastatin—coronary artery disease	0.00337	0.0132	CbGbCtD
Dasatinib—CYP3A4—Enalapril—coronary artery disease	0.00313	0.0123	CbGbCtD
Dasatinib—ABCB1—Losartan—coronary artery disease	0.00308	0.0121	CbGbCtD
Dasatinib—CYP3A4—Ezetimibe—coronary artery disease	0.00243	0.00957	CbGbCtD
Dasatinib—CYP3A4—Rosuvastatin—coronary artery disease	0.00243	0.00957	CbGbCtD
Dasatinib—EPHA2—pulmonary artery—coronary artery disease	0.00226	0.0399	CbGeAlD
Dasatinib—CYP3A4—Simvastatin—coronary artery disease	0.00226	0.00889	CbGbCtD
Dasatinib—CYP3A4—Lovastatin—coronary artery disease	0.00221	0.0087	CbGbCtD
Dasatinib—CYP3A4—Pravastatin—coronary artery disease	0.00221	0.0087	CbGbCtD
Dasatinib—CYP3A4—Atorvastatin—coronary artery disease	0.00202	0.00793	CbGbCtD
Dasatinib—CYP3A4—Losartan—coronary artery disease	0.00184	0.00725	CbGbCtD
Dasatinib—RIPK2—endothelium—coronary artery disease	0.000855	0.0151	CbGeAlD
Dasatinib—TESK1—Enalapril—Captopril—coronary artery disease	0.000812	0.345	CbGdCrCtD
Dasatinib—SIK3—myocardium—coronary artery disease	0.000764	0.0135	CbGeAlD
Dasatinib—TEC—blood—coronary artery disease	0.000758	0.0133	CbGeAlD
Dasatinib—SRC—artery—coronary artery disease	0.000727	0.0128	CbGeAlD
Dasatinib—EPHB4—endothelium—coronary artery disease	0.000722	0.0127	CbGeAlD
Dasatinib—BMX—heart—coronary artery disease	0.00067	0.0118	CbGeAlD
Dasatinib—BMX—cardiovascular system—coronary artery disease	0.000632	0.0111	CbGeAlD
Dasatinib—TESK1—myocardium—coronary artery disease	0.000628	0.0111	CbGeAlD
Dasatinib—STK35—cardiac ventricle—coronary artery disease	0.000616	0.0108	CbGeAlD
Dasatinib—SRC—endothelium—coronary artery disease	0.000614	0.0108	CbGeAlD
Dasatinib—CSK—cardiac ventricle—coronary artery disease	0.000612	0.0108	CbGeAlD
Dasatinib—STAT5B—heart—coronary artery disease	0.000593	0.0105	CbGeAlD
Dasatinib—STK35—myocardium—coronary artery disease	0.000579	0.0102	CbGeAlD
Dasatinib—CSK—myocardium—coronary artery disease	0.000575	0.0101	CbGeAlD
Dasatinib—HCK—myocardium—coronary artery disease	0.000568	0.01	CbGeAlD
Dasatinib—STAT5B—cardiovascular system—coronary artery disease	0.00056	0.00986	CbGeAlD
Dasatinib—SIK1—cardiac ventricle—coronary artery disease	0.000554	0.00977	CbGeAlD
Dasatinib—EPHA3—heart—coronary artery disease	0.000548	0.00966	CbGeAlD
Dasatinib—RIPK2—myocardium—coronary artery disease	0.000534	0.00941	CbGeAlD
Dasatinib—SIK3—heart—coronary artery disease	0.000533	0.0094	CbGeAlD
Dasatinib—SIK1—myocardium—coronary artery disease	0.000521	0.00919	CbGeAlD
Dasatinib—EPHA4—myocardium—coronary artery disease	0.000516	0.00909	CbGeAlD
Dasatinib—PKMYT1—blood—coronary artery disease	0.000512	0.00902	CbGeAlD
Dasatinib—KIT—endothelium—coronary artery disease	0.000501	0.00882	CbGeAlD
Dasatinib—BMX—blood—coronary artery disease	0.0005	0.0088	CbGeAlD
Dasatinib—ZAK—heart—coronary artery disease	0.000496	0.00874	CbGeAlD
Dasatinib—BLK—blood—coronary artery disease	0.000494	0.0087	CbGeAlD
Dasatinib—EPHB4—cardiac ventricle—coronary artery disease	0.00048	0.00845	CbGeAlD
Dasatinib—JAK2—cardiac ventricle—coronary artery disease	0.000476	0.00839	CbGeAlD
Dasatinib—TXK—blood—coronary artery disease	0.000473	0.00833	CbGeAlD
Dasatinib—FYN—cardiac ventricle—coronary artery disease	0.00047	0.00828	CbGeAlD
Dasatinib—PTK6—blood—coronary artery disease	0.000468	0.00825	CbGeAlD
Dasatinib—ZAK—cardiovascular system—coronary artery disease	0.000468	0.00824	CbGeAlD
Dasatinib—TNK2—heart—coronary artery disease	0.000466	0.00821	CbGeAlD
Dasatinib—MAP3K3—cardiac ventricle—coronary artery disease	0.000459	0.00809	CbGeAlD
Dasatinib—SIK3—cardiac atrium—coronary artery disease	0.000456	0.00804	CbGeAlD
Dasatinib—EPHB4—myocardium—coronary artery disease	0.000451	0.00795	CbGeAlD
Dasatinib—JAK2—myocardium—coronary artery disease	0.000448	0.00789	CbGeAlD
Dasatinib—STAT5B—blood—coronary artery disease	0.000443	0.0078	CbGeAlD
Dasatinib—FYN—myocardium—coronary artery disease	0.000442	0.00778	CbGeAlD
Dasatinib—TESK1—Enalapril—Perindopril—coronary artery disease	0.000439	0.186	CbGdCrCtD
Dasatinib—TESK1—heart—coronary artery disease	0.000438	0.00772	CbGeAlD
Dasatinib—MAP3K3—myocardium—coronary artery disease	0.000432	0.00761	CbGeAlD
Dasatinib—STK36—heart—coronary artery disease	0.000431	0.0076	CbGeAlD
Dasatinib—EPHB3—heart—coronary artery disease	0.000431	0.0076	CbGeAlD
Dasatinib—YES1—cardiac ventricle—coronary artery disease	0.000424	0.00747	CbGeAlD
Dasatinib—LIMK2—heart—coronary artery disease	0.000417	0.00735	CbGeAlD
Dasatinib—STK35—heart—coronary artery disease	0.000404	0.00712	CbGeAlD
Dasatinib—CSK—heart—coronary artery disease	0.000402	0.00708	CbGeAlD
Dasatinib—YES1—myocardium—coronary artery disease	0.000399	0.00703	CbGeAlD
Dasatinib—HCK—heart—coronary artery disease	0.000396	0.00698	CbGeAlD
Dasatinib—ABL2—heart—coronary artery disease	0.000394	0.00694	CbGeAlD
Dasatinib—CSK—cardiovascular system—coronary artery disease	0.000379	0.00668	CbGeAlD
Dasatinib—TESK1—cardiac atrium—coronary artery disease	0.000375	0.00661	CbGeAlD
Dasatinib—RIPK2—heart—coronary artery disease	0.000373	0.00657	CbGeAlD
Dasatinib—ZAK—blood—coronary artery disease	0.00037	0.00652	CbGeAlD
Dasatinib—SIK1—heart—coronary artery disease	0.000364	0.00641	CbGeAlD
Dasatinib—EPHA4—heart—coronary artery disease	0.00036	0.00635	CbGeAlD
Dasatinib—LYN—blood—coronary artery disease	0.00036	0.00635	CbGeAlD
Dasatinib—ERBB3—heart—coronary artery disease	0.000357	0.00629	CbGeAlD
Dasatinib—MAP3K2—heart—coronary artery disease	0.000353	0.00623	CbGeAlD
Dasatinib—BTK—blood—coronary artery disease	0.000353	0.00622	CbGeAlD
Dasatinib—MAP2K5—myocardium—coronary artery disease	0.000353	0.00622	CbGeAlD
Dasatinib—RIPK2—cardiovascular system—coronary artery disease	0.000352	0.0062	CbGeAlD
Dasatinib—STK35—cardiac atrium—coronary artery disease	0.000346	0.00609	CbGeAlD
Dasatinib—CSK—cardiac atrium—coronary artery disease	0.000343	0.00605	CbGeAlD
Dasatinib—TESK1—Enalapril—Trandolapril—coronary artery disease	0.000342	0.145	CbGdCrCtD
Dasatinib—MAPK14—heart—coronary artery disease	0.000332	0.00585	CbGeAlD
Dasatinib—LCK—heart—coronary artery disease	0.000331	0.00583	CbGeAlD
Dasatinib—FGR—heart—coronary artery disease	0.000331	0.00583	CbGeAlD
Dasatinib—TESK1—blood—coronary artery disease	0.000327	0.00576	CbGeAlD
Dasatinib—PDGFRB—cardiac ventricle—coronary artery disease	0.000325	0.00572	CbGeAlD
Dasatinib—STK36—blood—coronary artery disease	0.000322	0.00567	CbGeAlD
Dasatinib—FMO3—heart—coronary artery disease	0.00032	0.00563	CbGeAlD
Dasatinib—RIPK2—cardiac atrium—coronary artery disease	0.000319	0.00562	CbGeAlD
Dasatinib—EPHB4—heart—coronary artery disease	0.000315	0.00555	CbGeAlD
Dasatinib—MAPK14—cardiovascular system—coronary artery disease	0.000313	0.00552	CbGeAlD
Dasatinib—KIT—myocardium—coronary artery disease	0.000313	0.00551	CbGeAlD
Dasatinib—JAK2—heart—coronary artery disease	0.000313	0.00551	CbGeAlD
Dasatinib—FGR—cardiovascular system—coronary artery disease	0.000312	0.0055	CbGeAlD
Dasatinib—SIK1—cardiac atrium—coronary artery disease	0.000311	0.00548	CbGeAlD
Dasatinib—LIMK2—blood—coronary artery disease	0.000311	0.00548	CbGeAlD
Dasatinib—EPHA2—heart—coronary artery disease	0.000309	0.00544	CbGeAlD
Dasatinib—FYN—heart—coronary artery disease	0.000308	0.00543	CbGeAlD
Dasatinib—EPHA4—cardiac atrium—coronary artery disease	0.000308	0.00543	CbGeAlD
Dasatinib—PDGFRB—myocardium—coronary artery disease	0.000305	0.00538	CbGeAlD
Dasatinib—MAP4K5—heart—coronary artery disease	0.000301	0.00531	CbGeAlD
Dasatinib—MAP3K3—heart—coronary artery disease	0.000301	0.00531	CbGeAlD
Dasatinib—CSK—blood—coronary artery disease	0.0003	0.00528	CbGeAlD
Dasatinib—EPHB4—cardiovascular system—coronary artery disease	0.000297	0.00524	CbGeAlD
Dasatinib—HCK—blood—coronary artery disease	0.000296	0.00521	CbGeAlD
Dasatinib—JAK2—cardiovascular system—coronary artery disease	0.000295	0.0052	CbGeAlD
Dasatinib—ABL2—blood—coronary artery disease	0.000294	0.00518	CbGeAlD
Dasatinib—EPHA2—cardiovascular system—coronary artery disease	0.000292	0.00514	CbGeAlD
Dasatinib—FYN—cardiovascular system—coronary artery disease	0.000291	0.00513	CbGeAlD
Dasatinib—ABL1—cardiac ventricle—coronary artery disease	0.000289	0.0051	CbGeAlD
Dasatinib—EPHB6—heart—coronary artery disease	0.000288	0.00507	CbGeAlD
Dasatinib—MAP3K3—cardiovascular system—coronary artery disease	0.000284	0.00501	CbGeAlD
Dasatinib—YES1—heart—coronary artery disease	0.000278	0.0049	CbGeAlD
Dasatinib—RIPK2—blood—coronary artery disease	0.000278	0.0049	CbGeAlD
Dasatinib—PDGFRA—heart—coronary artery disease	0.000273	0.00481	CbGeAlD
Dasatinib—ABL1—myocardium—coronary artery disease	0.000272	0.0048	CbGeAlD
Dasatinib—SIK1—blood—coronary artery disease	0.000272	0.00479	CbGeAlD
Dasatinib—EPHB4—cardiac atrium—coronary artery disease	0.000269	0.00475	CbGeAlD
Dasatinib—EPHA4—blood—coronary artery disease	0.000269	0.00474	CbGeAlD
Dasatinib—TESK1—Enalapril—Lisinopril—coronary artery disease	0.000268	0.114	CbGdCrCtD
Dasatinib—SRC—heart—coronary artery disease	0.000268	0.00472	CbGeAlD
Dasatinib—JAK2—cardiac atrium—coronary artery disease	0.000267	0.00471	CbGeAlD
Dasatinib—EPHA2—cardiac atrium—coronary artery disease	0.000264	0.00466	CbGeAlD
Dasatinib—FYN—cardiac atrium—coronary artery disease	0.000264	0.00465	CbGeAlD
Dasatinib—MAP3K2—blood—coronary artery disease	0.000264	0.00465	CbGeAlD
Dasatinib—TESK1—Enalapril—Ramipril—coronary artery disease	0.00026	0.11	CbGdCrCtD
Dasatinib—MAP3K3—cardiac atrium—coronary artery disease	0.000258	0.00454	CbGeAlD
Dasatinib—MAP4K5—cardiac atrium—coronary artery disease	0.000258	0.00454	CbGeAlD
Dasatinib—PDGFRA—cardiovascular system—coronary artery disease	0.000258	0.00454	CbGeAlD
Dasatinib—SRC—cardiovascular system—coronary artery disease	0.000253	0.00445	CbGeAlD
Dasatinib—MAPK14—blood—coronary artery disease	0.000248	0.00437	CbGeAlD
Dasatinib—FGR—blood—coronary artery disease	0.000247	0.00435	CbGeAlD
Dasatinib—LCK—blood—coronary artery disease	0.000247	0.00435	CbGeAlD
Dasatinib—EPHB6—cardiac atrium—coronary artery disease	0.000246	0.00434	CbGeAlD
Dasatinib—MAP2K5—heart—coronary artery disease	0.000246	0.00434	CbGeAlD
Dasatinib—CSF1R—heart—coronary artery disease	0.00024	0.00424	CbGeAlD
Dasatinib—YES1—cardiac atrium—coronary artery disease	0.000238	0.00419	CbGeAlD
Dasatinib—ERBB3—Alprenolol—Penbutolol—coronary artery disease	0.000235	0.0999	CbGdCrCtD
Dasatinib—EPHB4—blood—coronary artery disease	0.000235	0.00414	CbGeAlD
Dasatinib—JAK2—blood—coronary artery disease	0.000233	0.00411	CbGeAlD
Dasatinib—MAP2K5—cardiovascular system—coronary artery disease	0.000232	0.0041	CbGeAlD
Dasatinib—EPHA2—blood—coronary artery disease	0.000231	0.00406	CbGeAlD
Dasatinib—FYN—blood—coronary artery disease	0.00023	0.00405	CbGeAlD
Dasatinib—SRC—cardiac atrium—coronary artery disease	0.000229	0.00403	CbGeAlD
Dasatinib—CSF1R—cardiovascular system—coronary artery disease	0.000227	0.004	CbGeAlD
Dasatinib—MAP4K5—blood—coronary artery disease	0.000225	0.00396	CbGeAlD
Dasatinib—MAP3K3—blood—coronary artery disease	0.000225	0.00396	CbGeAlD
Dasatinib—KIT—heart—coronary artery disease	0.000218	0.00385	CbGeAlD
Dasatinib—EPHB6—blood—coronary artery disease	0.000215	0.00379	CbGeAlD
Dasatinib—PDGFRB—heart—coronary artery disease	0.000213	0.00376	CbGeAlD
Dasatinib—MAP2K5—cardiac atrium—coronary artery disease	0.000211	0.00371	CbGeAlD
Dasatinib—YES1—blood—coronary artery disease	0.000208	0.00366	CbGeAlD
Dasatinib—KIT—cardiovascular system—coronary artery disease	0.000206	0.00363	CbGeAlD
Dasatinib—CSF1R—cardiac atrium—coronary artery disease	0.000206	0.00362	CbGeAlD
Dasatinib—PDGFRA—blood—coronary artery disease	0.000204	0.00359	CbGeAlD
Dasatinib—PDGFRB—cardiovascular system—coronary artery disease	0.000201	0.00354	CbGeAlD
Dasatinib—SRC—blood—coronary artery disease	0.0002	0.00352	CbGeAlD
Dasatinib—ABL1—heart—coronary artery disease	0.00019	0.00335	CbGeAlD
Dasatinib—MAP2K5—blood—coronary artery disease	0.000184	0.00324	CbGeAlD
Dasatinib—PDGFRB—cardiac atrium—coronary artery disease	0.000182	0.00321	CbGeAlD
Dasatinib—CSF1R—blood—coronary artery disease	0.000179	0.00316	CbGeAlD
Dasatinib—ABL1—cardiovascular system—coronary artery disease	0.000179	0.00316	CbGeAlD
Dasatinib—CYP1A1—cardiac ventricle—coronary artery disease	0.000173	0.00305	CbGeAlD
Dasatinib—KIT—blood—coronary artery disease	0.000163	0.00287	CbGeAlD
Dasatinib—ABL1—cardiac atrium—coronary artery disease	0.000163	0.00286	CbGeAlD
Dasatinib—CYP1B1—heart—coronary artery disease	0.000161	0.00284	CbGeAlD
Dasatinib—PDGFRB—blood—coronary artery disease	0.000159	0.0028	CbGeAlD
Dasatinib—CYP1B1—cardiovascular system—coronary artery disease	0.000152	0.00268	CbGeAlD
Dasatinib—ABL1—blood—coronary artery disease	0.000142	0.0025	CbGeAlD
Dasatinib—CYP1B1—blood—coronary artery disease	0.00012	0.00212	CbGeAlD
Dasatinib—ABCG2—heart—coronary artery disease	0.00012	0.00211	CbGeAlD
Dasatinib—CYP1A1—heart—coronary artery disease	0.000114	0.002	CbGeAlD
Dasatinib—CYP1A1—cardiac atrium—coronary artery disease	9.73e-05	0.00171	CbGeAlD
Dasatinib—ABCG2—blood—coronary artery disease	8.94e-05	0.00158	CbGeAlD
Dasatinib—CYP1A2—blood—coronary artery disease	8.61e-05	0.00152	CbGeAlD
Dasatinib—CYP1A1—blood—coronary artery disease	8.49e-05	0.0015	CbGeAlD
Dasatinib—CYP3A5—blood—coronary artery disease	8.3e-05	0.00146	CbGeAlD
Dasatinib—CYP3A4—blood—coronary artery disease	6.23e-05	0.0011	CbGeAlD
Dasatinib—ABCB1—heart—coronary artery disease	5.91e-05	0.00104	CbGeAlD
Dasatinib—ABCB1—cardiovascular system—coronary artery disease	5.58e-05	0.000982	CbGeAlD
Dasatinib—ABCB1—blood—coronary artery disease	4.41e-05	0.000777	CbGeAlD
Dasatinib—Abdominal pain—Captopril—coronary artery disease	3.23e-05	0.000213	CcSEcCtD
Dasatinib—Dizziness—Simvastatin—coronary artery disease	3.22e-05	0.000212	CcSEcCtD
Dasatinib—Rash—Ezetimibe—coronary artery disease	3.22e-05	0.000212	CcSEcCtD
Dasatinib—Dermatitis—Ezetimibe—coronary artery disease	3.22e-05	0.000212	CcSEcCtD
Dasatinib—Confusional state—Ramipril—coronary artery disease	3.21e-05	0.000212	CcSEcCtD
Dasatinib—Discomfort—Timolol—coronary artery disease	3.21e-05	0.000212	CcSEcCtD
Dasatinib—Asthenia—Niacin—coronary artery disease	3.21e-05	0.000212	CcSEcCtD
Dasatinib—Fatigue—Losartan—coronary artery disease	3.21e-05	0.000211	CcSEcCtD
Dasatinib—Headache—Ezetimibe—coronary artery disease	3.2e-05	0.000211	CcSEcCtD
Dasatinib—Malaise—Lisinopril—coronary artery disease	3.19e-05	0.000211	CcSEcCtD
Dasatinib—Oedema—Ramipril—coronary artery disease	3.19e-05	0.00021	CcSEcCtD
Dasatinib—Vertigo—Lisinopril—coronary artery disease	3.18e-05	0.00021	CcSEcCtD
Dasatinib—Pain—Losartan—coronary artery disease	3.18e-05	0.00021	CcSEcCtD
Dasatinib—Constipation—Losartan—coronary artery disease	3.18e-05	0.00021	CcSEcCtD
Dasatinib—Syncope—Lisinopril—coronary artery disease	3.18e-05	0.00021	CcSEcCtD
Dasatinib—Vomiting—Eplerenone—coronary artery disease	3.18e-05	0.00021	CcSEcCtD
Dasatinib—Feeling abnormal—Furosemide—coronary artery disease	3.18e-05	0.000209	CcSEcCtD
Dasatinib—Nausea—Fenofibrate—coronary artery disease	3.17e-05	0.000209	CcSEcCtD
Dasatinib—Pruritus—Niacin—coronary artery disease	3.16e-05	0.000209	CcSEcCtD
Dasatinib—Asthenia—Pravastatin—coronary artery disease	3.16e-05	0.000208	CcSEcCtD
Dasatinib—Gastrointestinal pain—Furosemide—coronary artery disease	3.15e-05	0.000208	CcSEcCtD
Dasatinib—Rash—Eplerenone—coronary artery disease	3.15e-05	0.000208	CcSEcCtD
Dasatinib—Urticaria—Perindopril—coronary artery disease	3.15e-05	0.000208	CcSEcCtD
Dasatinib—Hypersensitivity—Trandolapril—coronary artery disease	3.15e-05	0.000208	CcSEcCtD
Dasatinib—Dermatitis—Eplerenone—coronary artery disease	3.15e-05	0.000208	CcSEcCtD
Dasatinib—Diarrhoea—Valsartan—coronary artery disease	3.15e-05	0.000207	CcSEcCtD
Dasatinib—Confusional state—Timolol—coronary artery disease	3.14e-05	0.000207	CcSEcCtD
Dasatinib—Shock—Ramipril—coronary artery disease	3.14e-05	0.000207	CcSEcCtD
Dasatinib—Hypersensitivity—Enalapril—coronary artery disease	3.14e-05	0.000207	CcSEcCtD
Dasatinib—Abdominal pain—Perindopril—coronary artery disease	3.13e-05	0.000207	CcSEcCtD
Dasatinib—Body temperature increased—Perindopril—coronary artery disease	3.13e-05	0.000207	CcSEcCtD
Dasatinib—Palpitations—Lisinopril—coronary artery disease	3.13e-05	0.000207	CcSEcCtD
Dasatinib—Diarrhoea—Olmesartan—coronary artery disease	3.13e-05	0.000206	CcSEcCtD
Dasatinib—Headache—Eplerenone—coronary artery disease	3.13e-05	0.000206	CcSEcCtD
Dasatinib—Nervous system disorder—Ramipril—coronary artery disease	3.13e-05	0.000206	CcSEcCtD
Dasatinib—Thrombocytopenia—Ramipril—coronary artery disease	3.12e-05	0.000206	CcSEcCtD
Dasatinib—Oedema—Timolol—coronary artery disease	3.12e-05	0.000206	CcSEcCtD
Dasatinib—Pruritus—Pravastatin—coronary artery disease	3.11e-05	0.000205	CcSEcCtD
Dasatinib—Loss of consciousness—Lisinopril—coronary artery disease	3.11e-05	0.000205	CcSEcCtD
Dasatinib—Nausea—Clopidogrel—coronary artery disease	3.11e-05	0.000205	CcSEcCtD
Dasatinib—Tachycardia—Ramipril—coronary artery disease	3.11e-05	0.000205	CcSEcCtD
Dasatinib—Skin disorder—Ramipril—coronary artery disease	3.1e-05	0.000204	CcSEcCtD
Dasatinib—Infection—Timolol—coronary artery disease	3.1e-05	0.000204	CcSEcCtD
Dasatinib—Vomiting—Simvastatin—coronary artery disease	3.09e-05	0.000204	CcSEcCtD
Dasatinib—Hypersensitivity—Telmisartan—coronary artery disease	3.09e-05	0.000204	CcSEcCtD
Dasatinib—Cough—Lisinopril—coronary artery disease	3.09e-05	0.000204	CcSEcCtD
Dasatinib—Nausea—Lovastatin—coronary artery disease	3.09e-05	0.000204	CcSEcCtD
Dasatinib—Hyperhidrosis—Ramipril—coronary artery disease	3.08e-05	0.000203	CcSEcCtD
Dasatinib—Rash—Simvastatin—coronary artery disease	3.07e-05	0.000202	CcSEcCtD
Dasatinib—Dermatitis—Simvastatin—coronary artery disease	3.07e-05	0.000202	CcSEcCtD
Dasatinib—Asthenia—Trandolapril—coronary artery disease	3.07e-05	0.000202	CcSEcCtD
Dasatinib—Shock—Timolol—coronary artery disease	3.07e-05	0.000202	CcSEcCtD
Dasatinib—Feeling abnormal—Losartan—coronary artery disease	3.06e-05	0.000202	CcSEcCtD
Dasatinib—Urticaria—Furosemide—coronary artery disease	3.06e-05	0.000202	CcSEcCtD
Dasatinib—Diarrhoea—Niacin—coronary artery disease	3.06e-05	0.000202	CcSEcCtD
Dasatinib—Nervous system disorder—Timolol—coronary artery disease	3.06e-05	0.000202	CcSEcCtD
Dasatinib—Asthenia—Enalapril—coronary artery disease	3.05e-05	0.000201	CcSEcCtD
Dasatinib—Headache—Simvastatin—coronary artery disease	3.05e-05	0.000201	CcSEcCtD
Dasatinib—Abdominal pain—Furosemide—coronary artery disease	3.05e-05	0.000201	CcSEcCtD
Dasatinib—Body temperature increased—Furosemide—coronary artery disease	3.05e-05	0.000201	CcSEcCtD
Dasatinib—Gastrointestinal pain—Losartan—coronary artery disease	3.04e-05	0.000201	CcSEcCtD
Dasatinib—Dizziness—Valsartan—coronary artery disease	3.04e-05	0.000201	CcSEcCtD
Dasatinib—Anorexia—Ramipril—coronary artery disease	3.04e-05	0.0002	CcSEcCtD
Dasatinib—Nausea—Ezetimibe—coronary artery disease	3.03e-05	0.0002	CcSEcCtD
Dasatinib—Skin disorder—Timolol—coronary artery disease	3.03e-05	0.0002	CcSEcCtD
Dasatinib—Dizziness—Olmesartan—coronary artery disease	3.03e-05	0.0002	CcSEcCtD
Dasatinib—Pruritus—Trandolapril—coronary artery disease	3.02e-05	0.000199	CcSEcCtD
Dasatinib—Chest pain—Lisinopril—coronary artery disease	3.02e-05	0.000199	CcSEcCtD
Dasatinib—Arthralgia—Lisinopril—coronary artery disease	3.02e-05	0.000199	CcSEcCtD
Dasatinib—Myalgia—Lisinopril—coronary artery disease	3.02e-05	0.000199	CcSEcCtD
Dasatinib—Hyperhidrosis—Timolol—coronary artery disease	3.01e-05	0.000199	CcSEcCtD
Dasatinib—Asthenia—Telmisartan—coronary artery disease	3.01e-05	0.000199	CcSEcCtD
Dasatinib—Pruritus—Enalapril—coronary artery disease	3.01e-05	0.000199	CcSEcCtD
Dasatinib—Diarrhoea—Pravastatin—coronary artery disease	3.01e-05	0.000199	CcSEcCtD
Dasatinib—Anxiety—Lisinopril—coronary artery disease	3.01e-05	0.000198	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.99e-05	0.000198	CcSEcCtD
Dasatinib—Discomfort—Lisinopril—coronary artery disease	2.98e-05	0.000197	CcSEcCtD
Dasatinib—Hypotension—Ramipril—coronary artery disease	2.98e-05	0.000197	CcSEcCtD
Dasatinib—Anorexia—Timolol—coronary artery disease	2.97e-05	0.000196	CcSEcCtD
Dasatinib—Pruritus—Telmisartan—coronary artery disease	2.97e-05	0.000196	CcSEcCtD
Dasatinib—Nausea—Eplerenone—coronary artery disease	2.97e-05	0.000196	CcSEcCtD
Dasatinib—Dizziness—Niacin—coronary artery disease	2.96e-05	0.000195	CcSEcCtD
Dasatinib—Urticaria—Losartan—coronary artery disease	2.95e-05	0.000195	CcSEcCtD
Dasatinib—Abdominal pain—Losartan—coronary artery disease	2.94e-05	0.000194	CcSEcCtD
Dasatinib—Body temperature increased—Losartan—coronary artery disease	2.94e-05	0.000194	CcSEcCtD
Dasatinib—Asthenia—Captopril—coronary artery disease	2.93e-05	0.000193	CcSEcCtD
Dasatinib—Diarrhoea—Trandolapril—coronary artery disease	2.92e-05	0.000193	CcSEcCtD
Dasatinib—Vomiting—Valsartan—coronary artery disease	2.92e-05	0.000193	CcSEcCtD
Dasatinib—Confusional state—Lisinopril—coronary artery disease	2.91e-05	0.000192	CcSEcCtD
Dasatinib—Diarrhoea—Enalapril—coronary artery disease	2.91e-05	0.000192	CcSEcCtD
Dasatinib—Hypotension—Timolol—coronary artery disease	2.91e-05	0.000192	CcSEcCtD
Dasatinib—Dizziness—Pravastatin—coronary artery disease	2.91e-05	0.000192	CcSEcCtD
Dasatinib—Vomiting—Olmesartan—coronary artery disease	2.91e-05	0.000192	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.9e-05	0.000192	CcSEcCtD
Dasatinib—Rash—Valsartan—coronary artery disease	2.9e-05	0.000191	CcSEcCtD
Dasatinib—Dermatitis—Valsartan—coronary artery disease	2.9e-05	0.000191	CcSEcCtD
Dasatinib—Nausea—Simvastatin—coronary artery disease	2.89e-05	0.000191	CcSEcCtD
Dasatinib—Oedema—Lisinopril—coronary artery disease	2.89e-05	0.000191	CcSEcCtD
Dasatinib—Pruritus—Captopril—coronary artery disease	2.89e-05	0.000191	CcSEcCtD
Dasatinib—Rash—Olmesartan—coronary artery disease	2.88e-05	0.00019	CcSEcCtD
Dasatinib—Insomnia—Ramipril—coronary artery disease	2.88e-05	0.00019	CcSEcCtD
Dasatinib—Dermatitis—Olmesartan—coronary artery disease	2.88e-05	0.00019	CcSEcCtD
Dasatinib—Headache—Valsartan—coronary artery disease	2.88e-05	0.00019	CcSEcCtD
Dasatinib—Diarrhoea—Telmisartan—coronary artery disease	2.87e-05	0.000189	CcSEcCtD
Dasatinib—Infection—Lisinopril—coronary artery disease	2.87e-05	0.000189	CcSEcCtD
Dasatinib—Headache—Olmesartan—coronary artery disease	2.87e-05	0.000189	CcSEcCtD
Dasatinib—Shock—Lisinopril—coronary artery disease	2.84e-05	0.000188	CcSEcCtD
Dasatinib—Asthenia—Perindopril—coronary artery disease	2.84e-05	0.000188	CcSEcCtD
Dasatinib—Dyspnoea—Ramipril—coronary artery disease	2.84e-05	0.000187	CcSEcCtD
Dasatinib—Vomiting—Niacin—coronary artery disease	2.84e-05	0.000187	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Timolol—coronary artery disease	2.84e-05	0.000187	CcSEcCtD
Dasatinib—Hypersensitivity—Furosemide—coronary artery disease	2.84e-05	0.000187	CcSEcCtD
Dasatinib—Somnolence—Ramipril—coronary artery disease	2.83e-05	0.000187	CcSEcCtD
Dasatinib—Thrombocytopenia—Lisinopril—coronary artery disease	2.83e-05	0.000187	CcSEcCtD
Dasatinib—Dizziness—Trandolapril—coronary artery disease	2.83e-05	0.000186	CcSEcCtD
Dasatinib—Tachycardia—Lisinopril—coronary artery disease	2.82e-05	0.000186	CcSEcCtD
Dasatinib—Insomnia—Timolol—coronary artery disease	2.82e-05	0.000186	CcSEcCtD
Dasatinib—Rash—Niacin—coronary artery disease	2.82e-05	0.000186	CcSEcCtD
Dasatinib—Dermatitis—Niacin—coronary artery disease	2.82e-05	0.000186	CcSEcCtD
Dasatinib—Dizziness—Enalapril—coronary artery disease	2.81e-05	0.000186	CcSEcCtD
Dasatinib—Skin disorder—Lisinopril—coronary artery disease	2.81e-05	0.000185	CcSEcCtD
Dasatinib—Dyspepsia—Ramipril—coronary artery disease	2.81e-05	0.000185	CcSEcCtD
Dasatinib—Pruritus—Perindopril—coronary artery disease	2.8e-05	0.000185	CcSEcCtD
Dasatinib—Headache—Niacin—coronary artery disease	2.8e-05	0.000185	CcSEcCtD
Dasatinib—Vomiting—Pravastatin—coronary artery disease	2.8e-05	0.000185	CcSEcCtD
Dasatinib—Hyperhidrosis—Lisinopril—coronary artery disease	2.79e-05	0.000184	CcSEcCtD
Dasatinib—Diarrhoea—Captopril—coronary artery disease	2.79e-05	0.000184	CcSEcCtD
Dasatinib—Dyspnoea—Timolol—coronary artery disease	2.78e-05	0.000183	CcSEcCtD
Dasatinib—Dizziness—Telmisartan—coronary artery disease	2.78e-05	0.000183	CcSEcCtD
Dasatinib—Rash—Pravastatin—coronary artery disease	2.77e-05	0.000183	CcSEcCtD
Dasatinib—Dermatitis—Pravastatin—coronary artery disease	2.77e-05	0.000183	CcSEcCtD
Dasatinib—Decreased appetite—Ramipril—coronary artery disease	2.77e-05	0.000183	CcSEcCtD
Dasatinib—Somnolence—Timolol—coronary artery disease	2.77e-05	0.000183	CcSEcCtD
Dasatinib—Asthenia—Furosemide—coronary artery disease	2.76e-05	0.000182	CcSEcCtD
Dasatinib—Headache—Pravastatin—coronary artery disease	2.76e-05	0.000182	CcSEcCtD
Dasatinib—Anorexia—Lisinopril—coronary artery disease	2.76e-05	0.000182	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Ramipril—coronary artery disease	2.75e-05	0.000182	CcSEcCtD
Dasatinib—Fatigue—Ramipril—coronary artery disease	2.75e-05	0.000181	CcSEcCtD
Dasatinib—Dyspepsia—Timolol—coronary artery disease	2.74e-05	0.000181	CcSEcCtD
Dasatinib—Hypersensitivity—Losartan—coronary artery disease	2.74e-05	0.000181	CcSEcCtD
Dasatinib—Nausea—Valsartan—coronary artery disease	2.73e-05	0.00018	CcSEcCtD
Dasatinib—Pruritus—Furosemide—coronary artery disease	2.73e-05	0.00018	CcSEcCtD
Dasatinib—Constipation—Ramipril—coronary artery disease	2.73e-05	0.00018	CcSEcCtD
Dasatinib—Nausea—Olmesartan—coronary artery disease	2.72e-05	0.000179	CcSEcCtD
Dasatinib—Vomiting—Trandolapril—coronary artery disease	2.72e-05	0.000179	CcSEcCtD
Dasatinib—Diarrhoea—Perindopril—coronary artery disease	2.71e-05	0.000179	CcSEcCtD
Dasatinib—Decreased appetite—Timolol—coronary artery disease	2.71e-05	0.000179	CcSEcCtD
Dasatinib—Vomiting—Enalapril—coronary artery disease	2.71e-05	0.000179	CcSEcCtD
Dasatinib—Hypotension—Lisinopril—coronary artery disease	2.7e-05	0.000178	CcSEcCtD
Dasatinib—Dizziness—Captopril—coronary artery disease	2.7e-05	0.000178	CcSEcCtD
Dasatinib—Rash—Trandolapril—coronary artery disease	2.69e-05	0.000178	CcSEcCtD
Dasatinib—Dermatitis—Trandolapril—coronary artery disease	2.69e-05	0.000178	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Timolol—coronary artery disease	2.69e-05	0.000177	CcSEcCtD
Dasatinib—Fatigue—Timolol—coronary artery disease	2.69e-05	0.000177	CcSEcCtD
Dasatinib—Rash—Enalapril—coronary artery disease	2.68e-05	0.000177	CcSEcCtD
Dasatinib—Dermatitis—Enalapril—coronary artery disease	2.68e-05	0.000177	CcSEcCtD
Dasatinib—Headache—Trandolapril—coronary artery disease	2.68e-05	0.000177	CcSEcCtD
Dasatinib—Vomiting—Telmisartan—coronary artery disease	2.67e-05	0.000176	CcSEcCtD
Dasatinib—Asthenia—Losartan—coronary artery disease	2.67e-05	0.000176	CcSEcCtD
Dasatinib—Headache—Enalapril—coronary artery disease	2.67e-05	0.000176	CcSEcCtD
Dasatinib—Pain—Timolol—coronary artery disease	2.66e-05	0.000176	CcSEcCtD
Dasatinib—Nausea—Niacin—coronary artery disease	2.65e-05	0.000175	CcSEcCtD
Dasatinib—Rash—Telmisartan—coronary artery disease	2.65e-05	0.000175	CcSEcCtD
Dasatinib—Dermatitis—Telmisartan—coronary artery disease	2.64e-05	0.000174	CcSEcCtD
Dasatinib—Diarrhoea—Furosemide—coronary artery disease	2.64e-05	0.000174	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.63e-05	0.000174	CcSEcCtD
Dasatinib—Pruritus—Losartan—coronary artery disease	2.63e-05	0.000174	CcSEcCtD
Dasatinib—Headache—Telmisartan—coronary artery disease	2.63e-05	0.000174	CcSEcCtD
Dasatinib—Feeling abnormal—Ramipril—coronary artery disease	2.63e-05	0.000173	CcSEcCtD
Dasatinib—Dizziness—Perindopril—coronary artery disease	2.62e-05	0.000173	CcSEcCtD
Dasatinib—Insomnia—Lisinopril—coronary artery disease	2.61e-05	0.000173	CcSEcCtD
Dasatinib—Nausea—Pravastatin—coronary artery disease	2.61e-05	0.000172	CcSEcCtD
Dasatinib—Gastrointestinal pain—Ramipril—coronary artery disease	2.61e-05	0.000172	CcSEcCtD
Dasatinib—Vomiting—Captopril—coronary artery disease	2.6e-05	0.000171	CcSEcCtD
Dasatinib—Dyspnoea—Lisinopril—coronary artery disease	2.58e-05	0.00017	CcSEcCtD
Dasatinib—Rash—Captopril—coronary artery disease	2.57e-05	0.00017	CcSEcCtD
Dasatinib—Dermatitis—Captopril—coronary artery disease	2.57e-05	0.00017	CcSEcCtD
Dasatinib—Somnolence—Lisinopril—coronary artery disease	2.57e-05	0.00017	CcSEcCtD
Dasatinib—Feeling abnormal—Timolol—coronary artery disease	2.57e-05	0.000169	CcSEcCtD
Dasatinib—Headache—Captopril—coronary artery disease	2.56e-05	0.000169	CcSEcCtD
Dasatinib—Gastrointestinal pain—Timolol—coronary artery disease	2.55e-05	0.000168	CcSEcCtD
Dasatinib—Dizziness—Furosemide—coronary artery disease	2.55e-05	0.000168	CcSEcCtD
Dasatinib—Dyspepsia—Lisinopril—coronary artery disease	2.54e-05	0.000168	CcSEcCtD
Dasatinib—Diarrhoea—Losartan—coronary artery disease	2.54e-05	0.000168	CcSEcCtD
Dasatinib—Nausea—Trandolapril—coronary artery disease	2.54e-05	0.000167	CcSEcCtD
Dasatinib—Urticaria—Ramipril—coronary artery disease	2.53e-05	0.000167	CcSEcCtD
Dasatinib—Nausea—Enalapril—coronary artery disease	2.53e-05	0.000167	CcSEcCtD
Dasatinib—Vomiting—Perindopril—coronary artery disease	2.52e-05	0.000166	CcSEcCtD
Dasatinib—Body temperature increased—Ramipril—coronary artery disease	2.52e-05	0.000166	CcSEcCtD
Dasatinib—Abdominal pain—Ramipril—coronary artery disease	2.52e-05	0.000166	CcSEcCtD
Dasatinib—Decreased appetite—Lisinopril—coronary artery disease	2.51e-05	0.000166	CcSEcCtD
Dasatinib—Rash—Perindopril—coronary artery disease	2.5e-05	0.000165	CcSEcCtD
Dasatinib—Dermatitis—Perindopril—coronary artery disease	2.5e-05	0.000165	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.5e-05	0.000165	CcSEcCtD
Dasatinib—Nausea—Telmisartan—coronary artery disease	2.49e-05	0.000165	CcSEcCtD
Dasatinib—Fatigue—Lisinopril—coronary artery disease	2.49e-05	0.000164	CcSEcCtD
Dasatinib—Headache—Perindopril—coronary artery disease	2.48e-05	0.000164	CcSEcCtD
Dasatinib—Urticaria—Timolol—coronary artery disease	2.48e-05	0.000163	CcSEcCtD
Dasatinib—Constipation—Lisinopril—coronary artery disease	2.47e-05	0.000163	CcSEcCtD
Dasatinib—Pain—Lisinopril—coronary artery disease	2.47e-05	0.000163	CcSEcCtD
Dasatinib—Body temperature increased—Timolol—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Dasatinib—Abdominal pain—Timolol—coronary artery disease	2.46e-05	0.000163	CcSEcCtD
Dasatinib—Dizziness—Losartan—coronary artery disease	2.46e-05	0.000162	CcSEcCtD
Dasatinib—Vomiting—Furosemide—coronary artery disease	2.45e-05	0.000162	CcSEcCtD
Dasatinib—Rash—Furosemide—coronary artery disease	2.43e-05	0.00016	CcSEcCtD
Dasatinib—Dermatitis—Furosemide—coronary artery disease	2.43e-05	0.00016	CcSEcCtD
Dasatinib—Nausea—Captopril—coronary artery disease	2.42e-05	0.00016	CcSEcCtD
Dasatinib—Headache—Furosemide—coronary artery disease	2.41e-05	0.000159	CcSEcCtD
Dasatinib—Feeling abnormal—Lisinopril—coronary artery disease	2.38e-05	0.000157	CcSEcCtD
Dasatinib—Gastrointestinal pain—Lisinopril—coronary artery disease	2.36e-05	0.000156	CcSEcCtD
Dasatinib—Vomiting—Losartan—coronary artery disease	2.36e-05	0.000156	CcSEcCtD
Dasatinib—Nausea—Perindopril—coronary artery disease	2.35e-05	0.000155	CcSEcCtD
Dasatinib—Hypersensitivity—Ramipril—coronary artery disease	2.35e-05	0.000155	CcSEcCtD
Dasatinib—Rash—Losartan—coronary artery disease	2.34e-05	0.000155	CcSEcCtD
Dasatinib—Dermatitis—Losartan—coronary artery disease	2.34e-05	0.000154	CcSEcCtD
Dasatinib—Headache—Losartan—coronary artery disease	2.33e-05	0.000154	CcSEcCtD
Dasatinib—Urticaria—Lisinopril—coronary artery disease	2.3e-05	0.000152	CcSEcCtD
Dasatinib—Hypersensitivity—Timolol—coronary artery disease	2.3e-05	0.000151	CcSEcCtD
Dasatinib—Nausea—Furosemide—coronary artery disease	2.29e-05	0.000151	CcSEcCtD
Dasatinib—Asthenia—Ramipril—coronary artery disease	2.29e-05	0.000151	CcSEcCtD
Dasatinib—Abdominal pain—Lisinopril—coronary artery disease	2.29e-05	0.000151	CcSEcCtD
Dasatinib—Body temperature increased—Lisinopril—coronary artery disease	2.29e-05	0.000151	CcSEcCtD
Dasatinib—Pruritus—Ramipril—coronary artery disease	2.26e-05	0.000149	CcSEcCtD
Dasatinib—Asthenia—Timolol—coronary artery disease	2.24e-05	0.000148	CcSEcCtD
Dasatinib—Nausea—Losartan—coronary artery disease	2.21e-05	0.000146	CcSEcCtD
Dasatinib—Pruritus—Timolol—coronary artery disease	2.2e-05	0.000145	CcSEcCtD
Dasatinib—Diarrhoea—Ramipril—coronary artery disease	2.18e-05	0.000144	CcSEcCtD
Dasatinib—Diarrhoea—Timolol—coronary artery disease	2.13e-05	0.000141	CcSEcCtD
Dasatinib—Hypersensitivity—Lisinopril—coronary artery disease	2.13e-05	0.000141	CcSEcCtD
Dasatinib—Dizziness—Ramipril—coronary artery disease	2.11e-05	0.000139	CcSEcCtD
Dasatinib—Asthenia—Lisinopril—coronary artery disease	2.07e-05	0.000137	CcSEcCtD
Dasatinib—Dizziness—Timolol—coronary artery disease	2.06e-05	0.000136	CcSEcCtD
Dasatinib—Pruritus—Lisinopril—coronary artery disease	2.05e-05	0.000135	CcSEcCtD
Dasatinib—Vomiting—Ramipril—coronary artery disease	2.03e-05	0.000134	CcSEcCtD
Dasatinib—Rash—Ramipril—coronary artery disease	2.01e-05	0.000133	CcSEcCtD
Dasatinib—Dermatitis—Ramipril—coronary artery disease	2.01e-05	0.000132	CcSEcCtD
Dasatinib—Headache—Ramipril—coronary artery disease	2e-05	0.000132	CcSEcCtD
Dasatinib—Vomiting—Timolol—coronary artery disease	1.98e-05	0.000131	CcSEcCtD
Dasatinib—Diarrhoea—Lisinopril—coronary artery disease	1.98e-05	0.00013	CcSEcCtD
Dasatinib—Rash—Timolol—coronary artery disease	1.96e-05	0.00013	CcSEcCtD
Dasatinib—Dermatitis—Timolol—coronary artery disease	1.96e-05	0.00013	CcSEcCtD
Dasatinib—Headache—Timolol—coronary artery disease	1.95e-05	0.000129	CcSEcCtD
Dasatinib—Dizziness—Lisinopril—coronary artery disease	1.91e-05	0.000126	CcSEcCtD
Dasatinib—Nausea—Ramipril—coronary artery disease	1.89e-05	0.000125	CcSEcCtD
Dasatinib—Nausea—Timolol—coronary artery disease	1.85e-05	0.000122	CcSEcCtD
Dasatinib—Vomiting—Lisinopril—coronary artery disease	1.84e-05	0.000121	CcSEcCtD
Dasatinib—Rash—Lisinopril—coronary artery disease	1.82e-05	0.00012	CcSEcCtD
Dasatinib—Dermatitis—Lisinopril—coronary artery disease	1.82e-05	0.00012	CcSEcCtD
Dasatinib—Headache—Lisinopril—coronary artery disease	1.81e-05	0.000119	CcSEcCtD
Dasatinib—Nausea—Lisinopril—coronary artery disease	1.72e-05	0.000113	CcSEcCtD
Dasatinib—CYP1A1—Metabolism—APOA1—coronary artery disease	3.26e-07	2.02e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.26e-07	2.01e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCND1—coronary artery disease	3.25e-07	2.01e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.24e-07	2e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—coronary artery disease	3.23e-07	2e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—GSK3B—coronary artery disease	3.23e-07	1.99e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CASP3—coronary artery disease	3.22e-07	1.99e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GSTM1—coronary artery disease	3.2e-07	1.98e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—coronary artery disease	3.2e-07	1.98e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CREB1—coronary artery disease	3.2e-07	1.98e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCA1—coronary artery disease	3.2e-07	1.98e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FGF2—coronary artery disease	3.2e-07	1.97e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—coronary artery disease	3.19e-07	1.97e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCND1—coronary artery disease	3.18e-07	1.96e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LIPC—coronary artery disease	3.18e-07	1.96e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.18e-07	1.96e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.18e-07	1.96e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HBA1—coronary artery disease	3.18e-07	1.96e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—PIK3CA—coronary artery disease	3.17e-07	1.96e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—MAPK1—coronary artery disease	3.16e-07	1.95e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—PIK3CA—coronary artery disease	3.16e-07	1.95e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOC3—coronary artery disease	3.16e-07	1.95e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—coronary artery disease	3.15e-07	1.95e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—coronary artery disease	3.15e-07	1.95e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—LPL—coronary artery disease	3.15e-07	1.94e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VEGFA—coronary artery disease	3.14e-07	1.94e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LDLR—coronary artery disease	3.14e-07	1.94e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—PIK3CA—coronary artery disease	3.13e-07	1.94e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—coronary artery disease	3.13e-07	1.93e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCND1—coronary artery disease	3.13e-07	1.93e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.12e-07	1.93e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6R—coronary artery disease	3.12e-07	1.93e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—coronary artery disease	3.1e-07	1.92e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—AKT1—coronary artery disease	3.1e-07	1.92e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.1e-07	1.91e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.1e-07	1.91e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT1—coronary artery disease	3.1e-07	1.91e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT1—coronary artery disease	3.1e-07	1.91e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CASP3—coronary artery disease	3.1e-07	1.91e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—coronary artery disease	3.09e-07	1.91e-06	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—AKT1—coronary artery disease	3.08e-07	1.91e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IGF1—coronary artery disease	3.08e-07	1.9e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GPX1—coronary artery disease	3.07e-07	1.9e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKT1—coronary artery disease	3.06e-07	1.89e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—JAK2—coronary artery disease	3.06e-07	1.89e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CETP—coronary artery disease	3.06e-07	1.89e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCLC—coronary artery disease	3.06e-07	1.89e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CASP3—coronary artery disease	3.06e-07	1.89e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—coronary artery disease	3.05e-07	1.88e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—PIK3CA—coronary artery disease	3.04e-07	1.88e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—coronary artery disease	3.04e-07	1.88e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—coronary artery disease	3.04e-07	1.88e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—coronary artery disease	3.04e-07	1.88e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—coronary artery disease	3.04e-07	1.88e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SDC1—coronary artery disease	3.03e-07	1.87e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—coronary artery disease	3.03e-07	1.87e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—AKT1—coronary artery disease	3.02e-07	1.87e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCND1—coronary artery disease	3.01e-07	1.86e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—coronary artery disease	3e-07	1.85e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CD36—coronary artery disease	2.99e-07	1.85e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAPK1—coronary artery disease	2.99e-07	1.85e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—coronary artery disease	2.98e-07	1.84e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCND1—coronary artery disease	2.98e-07	1.84e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—coronary artery disease	2.96e-07	1.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.95e-07	1.82e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—coronary artery disease	2.95e-07	1.82e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—coronary artery disease	2.93e-07	1.81e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—coronary artery disease	2.93e-07	1.81e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SERPINE1—coronary artery disease	2.92e-07	1.81e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—MAPK1—coronary artery disease	2.92e-07	1.8e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—coronary artery disease	2.92e-07	1.8e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PIK3CA—coronary artery disease	2.9e-07	1.79e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—PIK3CA—coronary artery disease	2.89e-07	1.79e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—coronary artery disease	2.89e-07	1.78e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—coronary artery disease	2.88e-07	1.78e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—coronary artery disease	2.88e-07	1.78e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKT1—coronary artery disease	2.86e-07	1.77e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.86e-07	1.77e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.86e-07	1.77e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—coronary artery disease	2.84e-07	1.75e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—coronary artery disease	2.83e-07	1.75e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VEGFA—coronary artery disease	2.83e-07	1.75e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FGF2—coronary artery disease	2.83e-07	1.75e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAPK1—coronary artery disease	2.83e-07	1.75e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—coronary artery disease	2.81e-07	1.74e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKT1—coronary artery disease	2.8e-07	1.73e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AKT1—coronary artery disease	2.8e-07	1.73e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—MAPK1—coronary artery disease	2.8e-07	1.73e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—coronary artery disease	2.8e-07	1.73e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—coronary artery disease	2.8e-07	1.73e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CTGF—coronary artery disease	2.8e-07	1.73e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AKT1—coronary artery disease	2.79e-07	1.73e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—coronary artery disease	2.79e-07	1.72e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.78e-07	1.72e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—coronary artery disease	2.77e-07	1.71e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VEGFA—coronary artery disease	2.77e-07	1.71e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.77e-07	1.71e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—coronary artery disease	2.77e-07	1.71e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.76e-07	1.7e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.75e-07	1.7e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—PIK3CA—coronary artery disease	2.74e-07	1.7e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—coronary artery disease	2.74e-07	1.69e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—AKT1—coronary artery disease	2.74e-07	1.69e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VEGFA—coronary artery disease	2.73e-07	1.69e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AKT1—coronary artery disease	2.72e-07	1.68e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—JAK2—coronary artery disease	2.71e-07	1.68e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAT—coronary artery disease	2.71e-07	1.67e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKT1—coronary artery disease	2.7e-07	1.67e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—coronary artery disease	2.69e-07	1.66e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—AKT1—coronary artery disease	2.69e-07	1.66e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AGT—coronary artery disease	2.69e-07	1.66e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CASP3—coronary artery disease	2.68e-07	1.65e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—coronary artery disease	2.64e-07	1.63e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—coronary artery disease	2.64e-07	1.63e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOB—coronary artery disease	2.63e-07	1.62e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VEGFA—coronary artery disease	2.63e-07	1.62e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—coronary artery disease	2.62e-07	1.62e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOA1—coronary artery disease	2.61e-07	1.61e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCND1—coronary artery disease	2.61e-07	1.61e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—coronary artery disease	2.6e-07	1.6e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VEGFA—coronary artery disease	2.59e-07	1.6e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AKT1—coronary artery disease	2.59e-07	1.6e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PIK3CA—coronary artery disease	2.59e-07	1.6e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—coronary artery disease	2.59e-07	1.6e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—MAPK1—coronary artery disease	2.58e-07	1.6e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKT1—coronary artery disease	2.58e-07	1.59e-06	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AKT1—coronary artery disease	2.58e-07	1.59e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—coronary artery disease	2.57e-07	1.59e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—coronary artery disease	2.56e-07	1.58e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AKT1—coronary artery disease	2.56e-07	1.58e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.56e-07	1.58e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK1—coronary artery disease	2.55e-07	1.57e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.55e-07	1.57e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—coronary artery disease	2.54e-07	1.57e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PIK3CA—coronary artery disease	2.53e-07	1.56e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—coronary artery disease	2.53e-07	1.56e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—LPL—coronary artery disease	2.51e-07	1.55e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—coronary artery disease	2.5e-07	1.55e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK1—coronary artery disease	2.49e-07	1.54e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—AKT1—coronary artery disease	2.49e-07	1.54e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—coronary artery disease	2.48e-07	1.53e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—coronary artery disease	2.47e-07	1.53e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.47e-07	1.53e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK1—coronary artery disease	2.46e-07	1.52e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PIK3CA—coronary artery disease	2.45e-07	1.52e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GPX1—coronary artery disease	2.45e-07	1.51e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—coronary artery disease	2.43e-07	1.5e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—PIK3CA—coronary artery disease	2.43e-07	1.5e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—coronary artery disease	2.41e-07	1.49e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.39e-07	1.48e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—coronary artery disease	2.39e-07	1.48e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—coronary artery disease	2.39e-07	1.48e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CD36—coronary artery disease	2.39e-07	1.47e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—coronary artery disease	2.38e-07	1.47e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKT1—coronary artery disease	2.37e-07	1.46e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CASP3—coronary artery disease	2.37e-07	1.46e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK1—coronary artery disease	2.36e-07	1.46e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKT1—coronary artery disease	2.36e-07	1.46e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.36e-07	1.46e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK1—coronary artery disease	2.33e-07	1.44e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCND1—coronary artery disease	2.31e-07	1.42e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—coronary artery disease	2.3e-07	1.42e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—coronary artery disease	2.3e-07	1.42e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VEGFA—coronary artery disease	2.27e-07	1.4e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—coronary artery disease	2.26e-07	1.4e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—coronary artery disease	2.26e-07	1.4e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—coronary artery disease	2.26e-07	1.4e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PIK3CA—coronary artery disease	2.26e-07	1.4e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—coronary artery disease	2.24e-07	1.39e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PIK3CA—coronary artery disease	2.24e-07	1.39e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—AKT1—coronary artery disease	2.24e-07	1.38e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—coronary artery disease	2.24e-07	1.38e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PIK3CA—coronary artery disease	2.21e-07	1.37e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—coronary artery disease	2.17e-07	1.34e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PIK3CA—coronary artery disease	2.16e-07	1.34e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—coronary artery disease	2.15e-07	1.33e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.15e-07	1.33e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AGT—coronary artery disease	2.15e-07	1.33e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PIK3CA—coronary artery disease	2.13e-07	1.32e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.13e-07	1.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.12e-07	1.31e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKT1—coronary artery disease	2.12e-07	1.31e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—coronary artery disease	2.1e-07	1.3e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAT—coronary artery disease	2.09e-07	1.29e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—coronary artery disease	2.09e-07	1.29e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOA1—coronary artery disease	2.08e-07	1.29e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—AKT1—coronary artery disease	2.07e-07	1.28e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—coronary artery disease	2.06e-07	1.28e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PIK3CA—coronary artery disease	2.06e-07	1.27e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PIK3CA—coronary artery disease	2.05e-07	1.27e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK1—coronary artery disease	2.04e-07	1.26e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOB—coronary artery disease	2.03e-07	1.25e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PIK3CA—coronary artery disease	2.03e-07	1.25e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VEGFA—coronary artery disease	2.01e-07	1.24e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKT1—coronary artery disease	2e-07	1.24e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.99e-07	1.23e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—coronary artery disease	1.99e-07	1.23e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—AKT1—coronary artery disease	1.98e-07	1.23e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—coronary artery disease	1.98e-07	1.22e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.97e-07	1.22e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—coronary artery disease	1.96e-07	1.21e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LPL—coronary artery disease	1.94e-07	1.2e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—coronary artery disease	1.92e-07	1.18e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GPX1—coronary artery disease	1.89e-07	1.17e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—coronary artery disease	1.89e-07	1.17e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—coronary artery disease	1.85e-07	1.14e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AKT1—coronary artery disease	1.85e-07	1.14e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CD36—coronary artery disease	1.84e-07	1.14e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—coronary artery disease	1.83e-07	1.13e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—AKT1—coronary artery disease	1.83e-07	1.13e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.82e-07	1.12e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—coronary artery disease	1.82e-07	1.12e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK1—coronary artery disease	1.81e-07	1.12e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—coronary artery disease	1.81e-07	1.12e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—coronary artery disease	1.81e-07	1.12e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKT1—coronary artery disease	1.81e-07	1.12e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—coronary artery disease	1.79e-07	1.11e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PIK3CA—coronary artery disease	1.77e-07	1.1e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKT1—coronary artery disease	1.77e-07	1.09e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.74e-07	1.08e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKT1—coronary artery disease	1.74e-07	1.08e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AKT1—coronary artery disease	1.68e-07	1.04e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKT1—coronary artery disease	1.68e-07	1.04e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AGT—coronary artery disease	1.66e-07	1.02e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKT1—coronary artery disease	1.65e-07	1.02e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—coronary artery disease	1.65e-07	1.02e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—coronary artery disease	1.62e-07	1e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOA1—coronary artery disease	1.61e-07	9.92e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—coronary artery disease	1.58e-07	9.74e-07	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—coronary artery disease	1.57e-07	9.7e-07	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PIK3CA—coronary artery disease	1.57e-07	9.7e-07	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.47e-07	9.1e-07	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKT1—coronary artery disease	1.45e-07	8.95e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.44e-07	8.91e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—coronary artery disease	1.41e-07	8.74e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—coronary artery disease	1.4e-07	8.62e-07	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3CA—coronary artery disease	1.39e-07	8.59e-07	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—coronary artery disease	1.39e-07	8.59e-07	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT1—coronary artery disease	1.28e-07	7.93e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—coronary artery disease	1.27e-07	7.86e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—coronary artery disease	1.22e-07	7.52e-07	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AKT1—coronary artery disease	1.2e-07	7.43e-07	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AKT1—coronary artery disease	1.14e-07	7.02e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.11e-07	6.87e-07	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.11e-07	6.86e-07	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AKT1—coronary artery disease	9.08e-08	5.61e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3CA—coronary artery disease	8.87e-08	5.48e-07	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKT1—coronary artery disease	7.25e-08	4.48e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.85e-08	4.23e-07	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKT1—coronary artery disease	5.59e-08	3.45e-07	CbGpPWpGaD
